Fulzerasib

NEW

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
TGM-T73190-1mg	1 mg	-	-	-	7 - 10 business days*	152.00€
TGM-T73190-5mg	5 mg	-	-	-	7 - 10 business days*	270.00€
TGM-T73190-10mg	10 mg	-	-	-	7 - 10 business days*	357.00€
TGM-T73190-1mL	1 ml (1 mL * 10 mM (in DMSO))	-	-	-	7 - 10 business days*	367.00€
TGM-T73190-25mg	25 mg	-	-	-	7 - 10 business days*	602.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Fulzerasib is an orally active KRAS G12C inhibitor that covalently binds to the... more

Close menu

Product information "Fulzerasib"

Description: Fulzerasib is an orally active KRAS G12C inhibitor that covalently binds to the cysteine residue on the protein, thereby inhibiting the growth of KRAS G12C mutant tumour cell lines, with an IC50 of 2â?"20 nM, and can be used to treat KRAS G12C mutant non-small cell lung cancer (NSCLC). Target: Ras, Kras. Smiles: O=C(C=C)N1CCN2C=3C=4C=C(Cl)C(=NC4N(C(=O)C3N(C(=O)C2C1)C)C=5C(=NC=CC5C)C(C)C)C=6C(F)=CC=CC6O. References: Rafael Rosell, et al. KRAS G12C-mutant driven non-small cell lung cancer (NSCLC). Crit Rev Oncol Hematol. 2024 Mar:195:104228.

Keywords:	GFH 925
Supplier:	TargetMol
Supplier-Nr:	T73190

Properties

MW:	617.07 D
Formula:	C32H30ClFN6O4

Database Information

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Fulzerasib"

Write a review